General Information of the Compound
Compound ID
CP0071951
Compound Name
(E)-3-[4-[(E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-enyl]phenyl]prop-2-enoic acid
    Show/Hide
Synonyms
ARN-810
    Show/Hide
Structure
Formula
C26H20ClFN2O2
Molecular Weight
446.909
Canonical SMILES
CC\C(=C(\c1ccc(\C=C\C(O)=O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl
    Show/Hide
InChI
InChI=1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+
    Show/Hide
InChIKey
BURHGPHDEVGCEZ-KJGLQBJMSA-N
CAS
1365888-06-7
Physicochemical Property
logP
6.8223
Rotatable Bonds
6
Heavy Atom Count
32
Polar Areas
65.98
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56941241
SID: 135643474
ChEMBL ID
CHEMBL3581693
DrugBank ID
DB12253
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00886, Estrogen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000083 MCF-7 Homo sapiens (Human)  4
1
EC50 = 0.7 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.5 nM
   TI
   LI
   LO
   TS
3
IC50 = 0.85 nM
   TI
   LI
   LO
   TS
4
IC50 = 24 nM
   TI
   LI
   LO
   TS
CL000078 T-47D Homo sapiens (Human)  2
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS
2
IC50 = 5.31 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 6.1 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CL000083 MCF-7 Homo sapiens (Human)  1
1
EC50 = 17 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( ARN-810 )
Drug Name ARN-810
Company Seragon pharmaceuticals
Indication
Breast cancer
Phase 2
Target(s)
Estrogen receptor (ESR)
Modulator